(Q38724794)

English

High early growth response 1 (EGR1) expression correlates with resistance to anti-EGFR treatment in vitro and with poorer outcome in metastatic colorectal cancer patients treated with cetuximab.

scientific article published on 22 December 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28005260%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

High early growth response 1 (EGR1) expression correlates with resistance to anti-EGFR treatment in vitro and with poorer outcome in metastatic colorectal cancer patients treated with cetuximab (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28005260%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

colorectal cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

metastatic colon cancer

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28005260%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Jennifer E Hardingham

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28005260%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

author name string

S S Kumar

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28005260%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Y Tomita

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28005260%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

M Bruhn

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28005260%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

A Swalling

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28005260%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

M Mohammed

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28005260%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

T J Price

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28005260%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

publication date

22 December 2016

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28005260%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Clinical and Translational Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28005260%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28005260%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28005260%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

718-726

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28005260%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

https://scigraph.springernature.com/pub.10.1007/s12094-016-1596-8

0 references

Biomarkers in colorectal cancer: the future is getting closer.

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1596-8

21 January 2018

K-ras mutations and benefit from cetuximab in advanced colorectal cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1596-8

21 January 2018

Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1596-8

21 January 2018

Overview of biomarkers in metastatic colorectal cancer: tumour, blood and patient-related factors.

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1596-8

21 January 2018

Massively parallel tumor multigene sequencing to evaluate response to panitumumab in a randomized phase III study of metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1596-8

21 January 2018

Effect of RAS status on anti-EGFR monoclonal antibodies + 5-FU infusion-based chemotherapy in first-line treatment of metastatic colorectal cancer: A meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1596-8

21 January 2018

Predictive role of BRAF mutations in patients with advanced colorectal cancer receiving cetuximab and panitumumab: a meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1596-8

21 January 2018

New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: do all roads lead to RAS?

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1596-8

21 January 2018

ESMO consensus guidelines for the management of patients with metastatic colorectal cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1596-8

21 January 2018

PIK3CA, BRAF, and PTEN status and benefit from cetuximab in the treatment of advanced colorectal cancer--results from NCIC CTG/AGITG CO.17.

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1596-8

21 January 2018

PIK3CA mutation/PTEN expression status predicts response of colon cancer cells to the epidermal growth factor receptor inhibitor cetuximab

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1596-8

21 January 2018

MYC Is a Major Determinant of Mitotic Cell Fate

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1596-8

21 January 2018

Cell survival and metastasis regulation by Akt signaling in colorectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1596-8

21 January 2018

A susceptibility gene set for early onset colorectal cancer that integrates diverse signaling pathways: implication for tumorigenesis.

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1596-8

21 January 2018

Gastrin inhibits a novel, pathological colon cancer signaling pathway involving EGR1, AE2, and P-ERK.

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1596-8

21 January 2018

The epidermal growth factor receptor pathway: a model for targeted therapy

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1596-8

21 January 2018

HER2 activating mutations are targets for colorectal cancer treatment

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1596-8

21 January 2018

Gene expression markers of efficacy and resistance to cetuximab treatment in metastatic colorectal cancer: results from CALGB 80203 (Alliance)

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1596-8

21 January 2018

TNF-α promotes invasive growth through the MET signaling pathway.

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1596-8

21 January 2018

Consistency test of the cell cycle: roles for p53 and EGR1.

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1596-8

21 January 2018

Phase III randomized, placebo-controlled study of cetuximab plus brivanib alaninate versus cetuximab plus placebo in patients with metastatic, chemotherapy-refractory, wild-type K-RAS colorectal carcinoma: the NCIC Clinical Trials Group and AGITG CO

1 reference

https://pubmed.ncbi.nlm.nih.gov/28005260

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulatory mechanisms of the HB-EGF autocrine loop in inflammation, homeostasis, development and cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/28005260

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early growth response-1 is a regulator of DR5-induced apoptosis in colon cancer cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/28005260

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Resistance to anti-EGFR therapy in colorectal cancer: from heterogeneity to convergent evolution

1 reference

https://pubmed.ncbi.nlm.nih.gov/28005260

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12094-016-1596-8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28005260%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28005260%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38724794&oldid=1506605610"